Abstract
Incorporation of l- or d-Tic into position 7 of oxytocin (OT) and its deamino analogue ([Mpa1]OT) resulted in four analogues, [l-Tic7]OT (1), [d-Tic7]OT (2), [Mpa1,l-Tic7]OT (3) and [Mpa1,d-Tic7]OT (4). Their biological properties were described by Fragiadaki et al. (Eur J Med Chem 42:799–806, 2007). Their NMR study (NOESY, TOCSY, 1H–13C HSQC spectra) is presented here. Analogues 1, 3 and 4 showed partial agonistic activity, analogue 2 was pure antagonist, suggesting that a cis conformation between residues 6 and 7 of the molecule does not result in antagonistic activity. However, the reduction in agonistic activity of analogues 1, 3 and 4 in comparison to oxytocin is consistent with the reduction of the trans conformation form. Binding affinity for the human oxytocin receptor with IC50 value of 130, 730, 103, and 380 nM for peptides 1, 2, 3, and 4, respectively, showed lower affinity in the case of d analogues. Deamination slightly increased the affinity. The existence of both cis and trans configurations of the Cys6-d-Tic7 bond is supported by observation of two sets of cross-peaks for 1H and 13C nuclei for most of the residues of the peptide not only in NOESY and TOCSY but also in 1H–13C HSQC spectra. The MS and HPLC indicate the presence of a single molecule/peptide, and NMR data thus suggest that this second set of peaks is due to the cis conformation.
Similar content being viewed by others
Abbreviations
- OT:
-
Oxytocin
- Mpa:
-
β-Mercaptopropionic acid
- [Mpa1]OT, dOT:
-
Deamino-oxytocin
- Tic:
-
1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid
- Fmoc:
-
9-Fluorenylmethoxycarbonyl
- But :
-
t-Butyl
- Trt:
-
Trityl
- DIC:
-
Diisopropylcarbodiimide
- HOBt:
-
1-Hydroxybenzotriazole
- DMF:
-
Dimethylformamide
- DMSO:
-
Dimethylsulfoxide
- TFA:
-
Trifluoroacetic acid
- HPLC:
-
High-performance liquid chromatography
- ESI-MS:
-
Electrospray ionization-Mass spectrometry
References
Bax A, Davis DG (1985) MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Reson 65:355–360
Bax A, Grzesiek S (1993) Methodological advances in protein NMR. Acc Chem Res 26:131–138
Belec L, Slaninova J, Lubell WD (2000) A study of the relationship between biological activity and prolyl amide isomer geometry in oxytocin using 5-tert-butylproline to augment the Cys6-Pro7 amide cis-isomer population. J Med Chem 43:1448–1455
Bélec L, Maletinska L, Slaninová J, Lubell WD (2001) The influence of steric interactions on the conformation and biology of oxytocin. Synthesis and analysis of penicillamine(6)-oxytocin and penicillamine(6)-5-tert-butylproline(7)-oxytocin analogs. J Pept Res 58:263–273
Bothner-By AA, Stephens RL, Lee JM, Warren CD, Jeanloz RW (1984) Structure determination of a tetrassacharide: transient nuclear overhauser effect in the rotating frame. J Am Chem Soc 106:811–813
Braunschweiler L, Ernst RR (1983) Coherence transfer by isotropic mixing: application to proton correlation spectroscopy. J Magn Reson 53:521–528
Budesinsky M, Ragnarsson U, Lankiewicz L, Grehn L, Slaninova J, Hlavacek J (2005) Synthesis and utilisation af 13C and 15N backbone-labelled proline: NMR study of synthesized oxytocin with backbone-labelled C-terminal tripeptide amid. Amino Acids 29:151–160
Budesínsky M, Procházka Z, Slaninová J (2005) Oxytocin and its analogs, methyl-substituted in ortho-, meta- or para-position of aromatic ring of phenylalanine in position 2: NMR study and biological activities. Protein Pept Lett 12:343–347
Eccles C, Güntert P, Billeter M, Wüthrich K (1991) Efficient analysis of protein 2D NMR spectra using the software package EASY. J Biomol NMR 1:111–130
Flouret G, Chaloin O, Borovickova L, Slaninova J (2006) Design of novel bicyclic analogues derived from a potent oxytocin antagonist. J Pept Sci 12:412–419
Fragiadaki M, Magafa V, Borovickova L, Slaninova J, Cordopatis P (2007) Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7. Eur J Med Chem 42:799–806
Grzonka Z, Lammek B, Kasprzykowski F, Gazis D, Schwartz IL (1983) Synthesis and some pharmacological properties of oxytocin and vasopressin analogues with sarcosine or N-methyl-l-alanine in position 7. J Med Chem 26:555–559
Grzonka Z, Mishra PK, Bothner-By AA (1985) Conformational preferences and binding to neurophysins of oxytocin analogues with sarcosine or N-methylalanine in position 7. Int J Pept Protein Res 25:375–381
Güntert P, Braun W, Wüthrich K (1991) Efficient computation of three-dimensional protein structures in solution from nuclear magnetic resonance data using the program DIANA and the supporting programs CALIBA, HABAS and GLOMSA. J Mol Biol 217:517–530
Güntert P, Mumenthaler C, Wüthrich K (1997) Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol 273:283–298
Harrison RK, Stein RL (1992) Mechanistic studies of enzymic and nonenzymic prolyl cis-trans isomerization. J Am Chem Soc 114:3464–3471
Hruby VJ, Lebl M (1987) Conformational properties of neurohypophyseal hormone analogs in solution as determined by NMR and Laser Raman Spectroscopies. In: Jost K, Lebl M, Brtnik F (eds) Handbook of neurohypophyseal hormone analogs, vol 1, part 1. CRC Press, Boca Raton, pp 105–154
Jeener J, Meier BH, Bachmann P, Ernst RR (1979) Investigation of exchange processes by two-dimensional NMR spectroscopy. J Chem Phys 71:4546–4553
Larive CK, Rabenstein DL (1993) Dynamics of cis/trans isomerization of the cysteine6-proline peptide bonds of oxytocin and arginine-vasopressin in aqueous and methanol solutions. J Am Chem Soc 115:2833–2836
Larive CK, Guerra L, Rabenstein DL (1992) Cis/trans conformational equilibrium across the cysteine6-proline peptide bond of oxytocin, arginine vasopressin, and lysine vasopressin. J Am Chem Soc 114:7331–7337
Lebl M, Hill P, Kazmierski W, Karaszova L, Slaninova J, Fric I, Hruvby VJ (1990) Conformationally restricted analogs of oxytocin; stabilization of inhibitory conformation. Int J Pept Protein Res 36:321–330
Lewis PN, Momany FA, Scheraga HA (1973) Chain reversals in proteins. Biochim Biophys Acta 303:211–229
Li X, Peterkofsky A, Wang G (2008) Solution structure of NPr, a bacterial signal-transducing protein that controls the phosphorylation state of the potassium transporter-regulating protein IIANtr. Amino Acids 35:531–539
Lowbridge J, Manning M, Haldar J, Sawyer WH (1977) Synthesis and some pharmacological properties of [4-threonine, 7-glycine]-oxytocin, [1-(l-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic selectivity. J Med Chem 20:120–123
Marik J, Budesinsky M, Slaninova J, Hlavacek J (2001) Synthesis, bioassay and NMR study of methyleneoxy isosters of oxytocin and vasopressin. Collect Czech Chem Commun 67:373–392
Marion D, Wüthrich K (1983) Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H–1H spin-spin coupling constants in proteins. Biochem Biophys Res Commun 113:967–974
Moore S, Felix AM, Meienhofer J, Smith CW, Walter R (1977) Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with l-3, 4-dehydroproline in position 7. J Med Chem 20:495–500
Oldziej S, Ciarkowski J, Liwo A, Shelderovich MD, Grzonka Z (1995) Conformational aspects of differences in requirements for oxytocin and vasopressin receptors. J Recept Signal Transduct Res 15:703–713
Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham TE, Ferguson DM, Seibel GL, Singh UC, Weiner PK, Kollman PA (1997) AMBER 5.0. University of California, San Francisco
Rodziewicz-Motowidlo S, Zhukov I, Kasprzykowski F, Grzonka Z, Ciarkowski J, Wojcik J (2002) Conformational solution studies of (Sar7) desamino and (MeAla7) desaminovasopressin analogues using NMR spectroscopy. J Pept Sci 8:347–364
Rodziewicz-Motowidlo S, Sikorska E, Oleszczuk M, Czaplewski C (2008) Conformational studies of vasopressin and mesotocin using NMR scectroscopy and molecular modelling methods. II. Studies in the SDS micelle. J Pept Sci 14:85–96
Rosamond JD, Ferger MF (1976) Synthesis and some pharmacologicalproperties of oxytocin analogues having l-thiazolidine-4-carboxylic acid in position 7. J Med Chem 19:873–876
Shenderovich MD, Koever KE, Wilke S, Collins N, Hruby VJ (1997) Solution conformations of potent bicyclic antagonists of oxytocin by nuclear magnetic resonance spectroscopy and molecular dynamics simulations. J Am Chem Soc 119:5833–5846
Sikorska E, Slusarz M, Slusarz R, Kowalczyk W, Lammek B (2006) Investigation of cis/trans ratios of peptide bonds in AVP analogues. J Pept Sci 12:13–24
Wittelsberger A, Patiny L, Slaninova J, Barberis C, Mutter M (2005) Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity. J Med Chem 48:6553–6562
Wood SP, Tickle IJ, Treharne AM, Pitts JE, Mascarenhas Y (1986) Crystal structure analysis of deaminooxytocin: conformational flexibility and receptor binding. Science 232:633–636
Wüthrich K, Billeter M, Brown W (1983) Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance. J Mol Biol 169:949–961
Zhou GP, Troy FA (2003) Characterization by NMR and molecular modeling of the binding of polyisoprenols (PI) and polyisoprenyl recognition sequence (PIRS) peptides: three-dimensional structure of the complexes reveals sites of specific interactions. Glycobiology 13:51–57
Zhou GP, Troy FA (2005) NMR studies on how the binding complex of polyisoprenol recognition sequence peptides and polyisoprenols can modulate membrane structure. Curr Protein Pept 6:399–411
Acknowledgments
Z.S. and G.A.S. wish to acknowledge EU-NMR program—Contract # RII3-026145 (CERM; Center of Magnetic Resonance, University of Florence) for access to NMR instrumentation. The work was partly supported by research project No. Z40550506 of the IOCBof the Academy of Sciences of the Czech Republic.
Author information
Authors and Affiliations
Corresponding author
Additional information
Abbreviations of common amino acids are in accordance with the recommendations of IUPAC-IUB Joint Commission on Biochemical Nomenclature: Arch Biochem Biophys 206 (1988) v–xxii, J Biol Chem 264 (1989) 668–673 and J Peptide Sci 12 (2006) 1–8.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Spyranti, Z., Fragiadaki, M., Magafa, V. et al. In position 7 l- and d-Tic-substituted oxytocin and deamino oxytocin: NMR study and conformational insights. Amino Acids 39, 539–548 (2010). https://doi.org/10.1007/s00726-009-0470-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-009-0470-1